Research News

20 June 2025

CHMP recommends third indication for darolutamide for patients with advanced prostate cancer

Orion’s collaboration partner Bayer announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended darolutamide, an oral androgen receptor inhibitor , plus androgen deprivation therapy for marketing authorisation in the European Union for the treatment of patients with metastatic hormone-sensitive prostate cancer
20 June 2025

Severe Polyneuritis Successfully Treated with CAR T-Cell Therapy

A team of physicians from Bochum are the first to successfully use CAR T-cell therapy to treat two patients with a rare autoimmune disease of the peripheral nervous system. This treatment modifies endogenous immune cells such that they can specifically target and eliminate B lymphocytes, which are here the origin of autoimmunity.
19 June 2025

Anti-aging drug Rapamycin extends lifespan as effectively as eating less

The anti-aging drug Rapamycin has the same life-extending effect as eating less, according to new research from the University of East Anglia and University of Glasgow
18 June 2025

Cancers Can Be Detected in the Bloodstream Three Years Prior to Diagnosis

Genetic material shed by tumors can be detected in the bloodstream three years prior to cancer diagnosis, according to a study led by investigators at the Ludwig Center at Johns Hopkins, Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public Health.
18 June 2025

Researchers identify new antibodies against current and future coronaviruses

Scientists have discovered a unique class of small antibodies that are strongly protective against a wide range of SARS coronaviruses, including SARS-CoV-1 and numerous early and recent SARS-CoV-2 variants.
16 June 2025

Dupilumab demonstrated superiority over Omalizumab in Chronic Rhinosinusitis with Nasal Polyps

Regeneron Pharmaceuticals, Inc. and Sanofi presented positive results from the EVEREST Phase 4 trial in adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting asthma. In the trial, Dupixent.
16 June 2025

Roche to advance prasinezumab into Phase III development for early-stage Parkinson's disease

Roche announced today its decision to proceed with Phase III development of prasinezumab, an investigational anti-alpha-synuclein antibody, in early-stage Parkinson’s disease.
13 June 2025

Newly discovered cancer cell energy pathway blocked with natural substance

Looking to nature for answers to complex questions can reveal new and unprecedented results that can even affect cells on molecular levels.
13 June 2025

Sea Cucumbers Could Hold Key to Stopping Cancer Spread

Sea cucumbers are the ocean's janitors, cleaning the seabed and recycling nutrients back into the water. But this humble marine invertebrate could also hold the key to stopping the spread of cancer.
10 June 2025

SGLT2 Inhibitors linked to reduced risk of Atrial Fibrillation in type 2 Diabetes

A new study published in the journal Diabetes, Obesity and Metabolism has found that sodium-glucose co-transporter-2 (SGLT2) inhibitors are associated with a reduced incidence of atrial fibrillation in patients with type 2 diabetes mellitus.